ArticleBiopreservation and biobanking2019
Ensuring Effective Utilization of Biospecimens: Design, Marketing, and Other Important Approaches.
Article in Biopreservation and biobanking, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 14 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
14 citing papers in PubMed.
- searchMECFS: An online, interactive platform to facilitate secondary use of biospecimens and associated research data from myalgic encephalomyelitis studies.Methods report (RTI Press) · 2026Article
- Decentralized Biobanking Pathway to Precision Medicine: Futures Study.Journal of medical Internet research · 2025Article
- Biobanking Legislation in Spain: Advancing or Undermining Its Ethical Values?Biopreservation and biobanking · 2024Article
- The Availability of Human Biospecimens to Support Biomarker Research.Biomarker insights · 2022Review
- Microbiome Forensic Biobanking: A Step toward Microbial Profiling for Forensic Human Identification.Healthcare (Basel, Switzerland) · 2021Article
- Collaborating with a Graduate Marketing Class to Boost Awareness of the AIDS and Cancer Specimen Resource.Biopreservation and biobanking · 2021Article
- Analysis of Biospecimen Demand and Utilization of Samples from the National Amyotrophic Lateral Sclerosis Biorepository.Biopreservation and biobanking · 2021Article
- Moving with the Times: The Health Science Alliance (HSA) Biobank, Pathway to Sustainability.Biomarker insights · 2021Article
- Opportunities and Risks for Research Biobanks in the COVID-19 Era and Beyond.Biopreservation and biobanking · 2020Review
- The Future of Biobanking: What Is Next?Biotech (Basel (Switzerland)) · 2020Article
- The Skeleton in the Closet: Faults and Strengths of Public Versus Private Genetic Biobanks.Biomolecules · 2020Article
- The Scale, Collections, and Biospecimen Distribution of Grade A Tertiary Hospital Biobanks in China: A National Survey.Frontiers in medicine · 2020Article
- The Importance of Human Tissue Bioresources in Advancing Biomedical Research.Biopreservation and biobanking · 2019Article
- The Utilization of Biospecimens: Impact of the Choice of Biobanking Model.Biopreservation and biobanking · 2019Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
2 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
A number of studies have shown that underutilization of biospecimens from bioresources (biobanks and biorepositories) is a significant concern. In addition, biospecimen underutilization has been identified as an ethical as well as practical concern. The utilization of biospecimens is affected by many factors, including the establishment of a scientific need for the biospecimens, the design of the bioresource, strategic planning, biospecimen quality and fitness for purpose, informed consent considerations, access policies and procedures, and marketing. This article discusses the impact of these factors on biospecimen utilization and provides suggestions for how bioresources can optimize biospecimen utilization from their collections.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.